Lyra therapeutics ipo date
WebAcum 1 zi · Get a real-time Lyra Therapeutics, Inc. (LYRA) stock price quote with breaking news, financials, statistics, charts and more. ... Earnings Date: May 9, 2024: ... IPO Date May 1, 2024. Employees 59. Stock Exchange NASDAQ. Ticker Symbol LYRA. Full … Web15 mai 2024 · LYRA: Get the latest Lyra Therapeutics stock price and detailed information including LYRA news, historical charts and realtime prices. ... Publish Date: 5/9/2024 …
Lyra therapeutics ipo date
Did you know?
Web29 mar. 2024 · LYRA THERAPEUTICS, INC. Consolidated Balance Sheets (in thousands, except share and per share data) December 31, 2024 2024 Assets Web8 mar. 2024 · Lyra Therapeutics (LYRA) will release its next earnings report on Mar 8, 2024. In the last quarter Lyra Therapeutics reported -$0.44 EPS in relation to -$0.4 …
WebFind the latest Lyra Therapeutics, Inc. (LYRA) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Earnings Date: May 08, … WebLyra Therapeutics is a clinical-stage company developing medicines precisely designed to target ear, nose and throat (ENT) diseases. Use the CB Insights Platform to explore Lyra …
Web21 apr. 2024 · Title: Impact of long-acting implantable corticosteroid matrices on SNOT-22 subdomains in CRS patients Date and Time: Thursday, April 28, 2024, at 9:32 – 9:40 … Web1 mai 2024 · Editor. Another pandemic biotech IPO has sold at the high range. Lyra Therapeutics said today their public offering, first filed in early March, raised $56 million, …
Web29 mar. 2024 · Lyra Therapeutics, Inc. is a clinical-stage biotechnology company developing therapies for the localized treatment of patients with chronic rhinosinusitis …
WebIPO Edge. Full Article 2 minutes read In the News Lyra Therapeutics Announces Pricing of Initial Public Offering. by IPO Edge. 3 years ago 2 minutes read Share on Facebook; … swati chhabra on instagramWebTrade Date. Lyra Therapeutics, Inc. LYRA - NASDAQ. $14.00-$16.00: $16.00: $21.00: 3.5 million: 5/1/2024: ... About Lyra Therapeutics, Inc. (adapted from Lyra Therapeutics, … sky bingo promotional codesWeb10 mai 2024 · First Quarter 2024 Financial Highlights. Cash and cash equivalents as of March 31, 2024 were $33.8 million, compared with $45.7 million at December 31, 2024, … swati chemicalsWeb24 mar. 2024 · Utrecht, Netherlands and Philadelphia USA, March 24, 2024 – LAVA Therapeutics B.V. (Nasdaq: LVTX), a biotechnology company focused on applying its … swati chaturvedi opindiaWeb27 apr. 2024 · Lyra Therapeutics aims to raise $52.5 million in an IPO of its common stock. The firm is advancing two drug candidates for the treatment of chronic rhinosinusitis. ... swati chemical industriesWeb8 nov. 2024 · WATERTOWN, Mass., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) ("Lyra" or the "Company"), a clinical-stage … swatic infotechWeb7 mar. 2024 · The company was formerly known as 480 Biomedical, Inc. and changed its name to Lyra Therapeutics, Inc. in July 2024. Lyra Therapeutics, Inc. was … swati cloud kitchen